3/9/2021
Assessment of KAN-101 in Celiac Disease (ACeD) Study Open
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingFeatured News
Tag: celiac disease clinical trial
7/4/2020
KAN-101 Phase 1 Clinical Trial Recruiting Now
The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue Reading12/18/2019
Latiglutenase for Celiac Disease Shows Symptom, Quality of Life Improvement
ImmunogenX, a clinical stage biotherapeutics company, has published the results of their phase 2 trial testing latiglutenase—an orally administered treatment for celiac disease (CD). Latiglutenase was shown to be safe…
Continue Reading10/24/2019
Cour Pharmaceuticals Announces Deal with Takeda for Celiac Treatment
Cour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a…
Continue Reading8/15/2019
First Patient Dosed in First Ever Phase 3 Clinical Trial for Celiac Disease
On August 13th, 2019, Innovate Biopharmaceuticals, Inc. (Innovate) announced the first patient has been dosed in its Phase 3 clinical trial for patients with celiac disease. The CeD LA 3001…
Continue ReadingRecent Posts
- Please Join Us for the Teal Pumpkin Project 2024!
- Why Aren't Most Rice Krispy Treats Gluten-Free?
- The 2024 Nobel Prize in Chemistry goes to a leading celiac disease researcher
- Cooking Up Health: New Paper Details How Culinary Medicine Can Empower Patients Living with Chronic Diseases
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...